Technology ID
TAB-4635
Virus isolation of the Florida strain of MERS-CoV for Anti-viral Research, Diagnostic and Vaccine Development
E-Numbers
E-058-2016-0
Lead Inventor
Tamin, Azaibi
Lead IC
CDC
Co-Inventors
Erdman, Dean
Tong, Suxiang (Sue)
ICs
CDC
Applications
Research Materials
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
This technology includes isolate of Middle East respiratory syndrome coronavirus (MERS-CoV) for antiviral and diagnostic development. The isolate was confirmed by full genome sequencing and further characterized by serologic and molecular testing and electron-microscopical studies. This is the first MERS-CoV strain isolated from a US imported case of MERS. The isolation of this virus underscores the importance of combing classic techniques such as virus isolation and electron microscopy and molecular techniques, such as real-time PCR and full genome sequencing, in identifying etiologic pathogens.
Commercial Applications
Valuable reagent for vaccine, diagnostic and anti-viral research and development.
Competitive Advantages
Multiple potential options for utilization, and is the first MERS-CoV strain isolated from a US imported case of MERS.
Licensing Contact: